ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,540.00
0.06%
S&P ASX All Technology
4,071.10
-0.14%
Brent Oil
74.125
-0.91%
US Dollar vs AUD
1.59688
0.31%
Bitcoin
96,159.87
-1.77%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Scopus BioPharma Inc (CE) (SCPS) Share Price

Scopus BioPharma Inc (CE)

Scopus BioPharma Inc (CE) (SCPS)

USOTC
0.0003
0.00
(0.00%)
Closed 14 February 8:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.0003
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.01
Market Cap
12.625k
Previous Close
0.0003
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,439
Shares Outstanding
42,084,264
Dividend Yield
-
PE Ratio
-0.62
Earnings Per Share (EPS)
-0.28
Revenue
-
Net Profit
-11.61M

About Scopus BioPharma Inc (CE)

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.scopusbiopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Scopus BioPharma Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SCPS. The last closing price for Scopus BioPharma (CE) was US$0. Over the last year, Scopus BioPharma (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.01.

Scopus BioPharma (CE) currently has 42,084,264 shares in issue. The market capitalisation of Scopus BioPharma (CE) is US$12,625.28 . Scopus BioPharma (CE) has a price to earnings ratio (PE ratio) of -0.62.

Ask ADVFN Intelligence (AI)

SCPS Latest News

More News

Form 1-Z -
Edgar (US Regulatory)
10 February 2024
SCPS (0.00%)

Form 15-12G - Securities registration termination [Section 12(g)]
Edgar (US Regulatory)
20 January 2024
SCPS (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
19 August 2023
SCPS (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
12 August 2023
SCPS (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
12 August 2023
SCPS (0.00%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
22 July 2023
SCPS (0.00%)

Form PRER14A - Preliminary Proxy Soliciting materials
Edgar (US Regulatory)
29 June 2023
SCPS (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00030.00030.00035530.0003CS
4000.00030.00030.000313450.0003CS
12000.00030.00050.000244390.00029994CS
260.0001500.00020.010.0001116430.0003106CS
52-0.0012-800.00150.011.0E-684810.00046148CS
156-0.0848-99.64747356050.08510.1561.0E-6238820.07259398CS
260-0.0848-99.64747356050.08510.1561.0E-6238820.07259398CS

SCPS - Frequently Asked Questions (FAQ)

What is the current Scopus BioPharma (CE) share price?
The current share price of Scopus BioPharma (CE) is US$ 0.0003
How many Scopus BioPharma (CE) shares are in issue?
Scopus BioPharma (CE) has 42,084,264 shares in issue
What is the market cap of Scopus BioPharma (CE)?
The market capitalisation of Scopus BioPharma (CE) is USD 12.63k
What is the 1 year trading range for Scopus BioPharma (CE) share price?
Scopus BioPharma (CE) has traded in the range of US$ 0.000001 to US$ 0.01 during the past year
What is the PE ratio of Scopus BioPharma (CE)?
The price to earnings ratio of Scopus BioPharma (CE) is -0.62
What is the reporting currency for Scopus BioPharma (CE)?
Scopus BioPharma (CE) reports financial results in USD
What is the latest annual profit for Scopus BioPharma (CE)?
The latest annual profit of Scopus BioPharma (CE) is USD -11.61M
What is the registered address of Scopus BioPharma (CE)?
The registered address for Scopus BioPharma (CE) is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Scopus BioPharma (CE) website address?
The website address for Scopus BioPharma (CE) is www.scopusbiopharma.com
Which industry sector does Scopus BioPharma (CE) operate in?
Scopus BioPharma (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.0246
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.027
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0246
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.027
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
GLNLFGalan Lithium Ltd (PK)
US$ 0.07885
(0.00%)
1.31M
PBNNFPt Bank Negara Indonesia (PK)
US$ 0.34295
(0.00%)
1.09M
SMNNYShimano Inc (PK)
US$ 14.11
(0.00%)
703k
KPRSFKeepers Holdings Inc (PK)
US$ 0.00
(0.00%)
339k
DKILYDaikin Industries Ltd (PK)
US$ 10.46
(0.00%)
230k

Discussion

View Full Feed
tw0122 tw0122 13 seconds ago
TCBP 600k float ? $4.50s +'30% now was at $5s 
TCBP
netmoney1999 netmoney1999 37 seconds ago
LOL Shaun and his paid pumpers are still clueless. Developing a proprietary communications system instead of using commercial standards? That makes regulatory and testing hurdles even that much higher to get approved for anything! The DoD will need to go over their code with a fine tooth comb and
ZENA
Konaploinks Konaploinks 52 seconds ago
Homework: IonQ is a leading company in the quantum computing industry, specializing in trapped-ion technology. They have been actively advancing hybrid quantum computing through various initiatives:

Integration with NVIDIA CUDA-Q Platform

IonQ has successfully demonstr
IONQ
EnchantedTitan62 EnchantedTitan62 2 minutes ago
Raising dividend effective on next payout date March 1st. However the share price trend has been downward the past few years. Might sell and put into MLPX.
MLPX
axelvento axelvento 2 minutes ago
Currently, Pfizer's stock is trading at just 18 times trailing earnings. And based on analyst projections, it's at a forward price-to-earnings multiple of less than 9
PFE
uranium-pinto-beans uranium-pinto-beans 2 minutes ago
Morning Reads


https://www.optionmillionaires.com/morning-reads-564/
BullNBear52 BullNBear52 2 minutes ago
~~COMPX 2/13/2025~~~~~~~

Previous Close

19649.95 +6.09

19752 BullNBear52
19555 SSKILLZ1
COMP
linkvest linkvest 3 minutes ago
Nah... right address and the right 🤡.... your on the iggy button...
RDAR
Paulie Pennies Paulie Pennies 3 minutes ago
The primary statute in the United States that makes it illegal to manipulate stocks is Section 10(b) of the Securities Exchange Act of 1934, along with Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission (SEC) under this section. Here's a brief explanation:

Section 1
ASII
kazzy kazzy 3 minutes ago
Another Korean mention, reiterating the sanctions against Wison and the SHI monopoly on FLNG, but further outlines another option:

Hanwha Ocean is emerging as a strong competitor to Samsung Heavy Industries as it has recently strengthened its business in offshore plants. Samsung Heavy
TGLO
Truth and Transparency Truth and Transparency 3 minutes ago
Mark Smith never fails to disappoint.
NB
Mr. C Mr. C 3 minutes ago
Hindsight is always 20/20. I’m sure we’ll all probably wish we bought more $TGLO at some point too
TGLO
Konaploinks Konaploinks 3 minutes ago
Homework: Heterogeneous quantum computing is an emerging approach that combines different types of quantum hardware (e.g., superconducting qubits, trapped ions, photonics, etc.) or integrates classical and quantum systems to optimize performance for specific tasks. Here are some key advances in thi
IONQ
BullNBear52 BullNBear52 3 minutes ago
The contract includes 2 opt outs. At $40M a year why opt out?
resx18 resx18 3 minutes ago
Good Morning $CBDW
CBDW
stocktowatch stocktowatch 3 minutes ago
$CSDX Tip Ranks Analysis - https://www.tipranks.com/stocks/csdx/technical-analysis
CSDX
gp22 gp22 4 minutes ago
AI EDGE COMPUTING: Bought more $OSS, AI Edge low float leader, on the dip.
Low float chip play $GSIT up nicely ..Will pull a $RGTI-like "Quantum Computing" move like when Quantum got discovered and went wild.. Bought more
$OSS, the other AI Edge low float target, on the dip.
GSIT OSS RGTI
eastunder eastunder 4 minutes ago
The Trade Desk Inc (TTD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts ...
GuruFocus News
Thu, February 13, 2025 at 12:18 AM MST 4 min read

https://finance.yahoo.com/news/trade-desk-inc-ttd-q4-071832087.html

Total Spend on Platform:
CTV DSP TTD
resx18 resx18 4 minutes ago
Good Morning $DTII
DTII
linkvest linkvest 4 minutes ago
Refresher on news for this years as follows:

Accredited Solutions, Inc. (OTC: ASII) Provides Revenue Guidance, Confirms Progress Toward Year 2 Target in 5-Year Strategic PlanNew Media Wire | 02/11/2025 https://www.otcmarkets.com/stock/ASII/news/story?e&id=3134333

G
ASII
ThunderousSeer8 ThunderousSeer8 4 minutes ago
I think you have the wrong address 🤡
RDAR
TrendTrade2016 TrendTrade2016 4 minutes ago
What a bunch of dummies here, I mean how stupid can people be. Billions in dilution and they still drink the poison kooky kool-aid
Lost sheep got slaughtered, RS coming next !
AFFU
AugustaFriends AugustaFriends 5 minutes ago
$MGOL break .73 will be huge .. next
MGOL
uranium-pinto-beans uranium-pinto-beans 5 minutes ago
While a hot inflation report on Wednesday initially made waves on Wall Street, the S&P 500 (SP500) ended the session just fine, while Treasury yields edged down after an earlier jump. Analysts are still discussing the developments (as well as reciprocal tariffs), though geopolitical headlines contin
AAPL CVX JPM

Your Recent History

USOTC
SCPS
Scopus BioPharma (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads